1. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
- Author
-
Fattal E and Fay F
- Subjects
- Animals, Anti-Inflammatory Agents administration & dosage, Anti-Inflammatory Agents therapeutic use, Drug Delivery Systems methods, Genes drug effects, Humans, Inflammation genetics, Nucleic Acids therapeutic use, Oligodeoxyribonucleotides, Antisense administration & dosage, Oligodeoxyribonucleotides, Antisense therapeutic use, RNA, Small Interfering administration & dosage, RNA, Small Interfering therapeutic use, Inflammation drug therapy, Nanomedicine methods, Nanoparticle Drug Delivery System, Nucleic Acids administration & dosage
- Abstract
Thanks to their abilities to modulate the expression of virtually any genes, RNA therapeutics have attracted considerable research efforts. Among the strategies focusing on nucleic acid gene inhibitors, antisense oligonucleotides and small interfering RNAs have reached advanced clinical trial phases with several of them having recently been marketed. These successes were obtained by overcoming stability and cellular delivery issues using either chemically modified nucleic acids or nanoparticles. As nucleic acid gene inhibitors are promising strategies to treat inflammatory diseases, this review focuses on the barriers, from manufacturing issues to cellular/subcellular delivery, that still need to be overcome to deliver the nucleic acids to sites of inflammation other than the liver. Furthermore, key examples of applications in rheumatoid arthritis, inflammatory bowel, and lung diseases are presented as case studies of systemic, oral, and lung nucleic acid delivery., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF